COVID-19 and heart failure: from epidemiology during the pandemic to myocardial injury, myocarditis, and heart failure sequelae
L Italia, D Tomasoni, S Bisegna, E Pancaldi… - Frontiers in …, 2021 - frontiersin.org
A close and intriguing relationship has been suggested between heart failure (HF) and
coronavirus disease 2019 (COVID-19). First, COVID-19 pandemic represented a global …
coronavirus disease 2019 (COVID-19). First, COVID-19 pandemic represented a global …
Long-term cardiovascular effects of COVID-19: emerging data relevant to the cardiovascular clinician
DL Tobler, AJ Pruzansky, S Naderi, AP Ambrosy… - Current atherosclerosis …, 2022 - Springer
Purpose of Review COVID-19 is now a global pandemic and the illness affects multiple
organ systems, including the cardiovascular system. Long-term cardiovascular …
organ systems, including the cardiovascular system. Long-term cardiovascular …
Prevalence, characteristics, and outcomes of COVID-19–associated acute myocarditis
E Ammirati, L Lupi, M Palazzini, NS Hendren… - Circulation, 2022 - Am Heart Assoc
Background: Acute myocarditis (AM) is thought to be a rare cardiovascular complication of
COVID-19, although minimal data are available beyond case reports. We aim to report the …
COVID-19, although minimal data are available beyond case reports. We aim to report the …
Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients
AJ Krauson, FVC Casimero, Z Siddiquee, JR Stone - npj Vaccines, 2023 - nature.com
At the start of the COVID-19 pandemic, the BNT162b2 (BioNTech-Pfizer) and mRNA-1273
(Moderna) mRNA vaccines were expediently designed and mass produced. Both vaccines …
(Moderna) mRNA vaccines were expediently designed and mass produced. Both vaccines …
Combined cardiac fluorodeoxyglucose–positron emission tomography/magnetic resonance imaging assessment of myocardial injury in patients who recently …
K Hanneman, C Houbois, A Schoffel… - JAMA …, 2022 - jamanetwork.com
Importance Although myocardial injury can occur with acute COVID-19, there is limited
understanding of changes with myocardial metabolism in recovered patients. Objective To …
understanding of changes with myocardial metabolism in recovered patients. Objective To …
[HTML][HTML] COVID-19–Associated cardiac pathology at the postmortem evaluation: a collaborative systematic review
R Almamlouk, T Kashour, S Obeidat, MC Bois… - Clinical Microbiology …, 2022 - Elsevier
Background Many postmortem studies address the cardiovascular effects of COVID-19 and
provide valuable information, but are limited by their small sample size. Objectives The aim …
provide valuable information, but are limited by their small sample size. Objectives The aim …
Cardiovascular complications of coronavirus disease-2019
CM Terzic, BJ Medina-Inojosa - Physical Medicine and …, 2023 - pmr.theclinics.com
In the initial 3 years of the pandemic, the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), the etiologic agent of coronavirus disease-2019 (COVID-19), has infected …
(SARS-CoV-2), the etiologic agent of coronavirus disease-2019 (COVID-19), has infected …
Cardiovascular disease in SARS‐CoV‐2 infection
Pre‐existing cardiovascular disease (CVD) increases the morbidity and mortality of COVID‐
19 and is strongly associated with poor disease outcomes. However, SARS‐CoV‐2 infection …
19 and is strongly associated with poor disease outcomes. However, SARS‐CoV‐2 infection …
Coronary microvascular dysfunction pathophysiology in COVID‐19
J Yin, S Wang, Y Liu, J Chen, D Li, T Xu - Microcirculation, 2021 - Wiley Online Library
Recently, accumulating evidence has highlighted the role of endothelial dysfunction in
COVID‐19 progression. Coronary microvascular dysfunction (CMD) plays a pivotal role in …
COVID‐19 progression. Coronary microvascular dysfunction (CMD) plays a pivotal role in …
Cardiac tissue model of immune-induced dysfunction reveals the role of free mitochondrial DNA and the therapeutic effects of exosomes
Despite tremendous progress in the development of mature heart-on-a-chip models, human
cell–based models of myocardial inflammation are lacking. Here, we bioengineered a …
cell–based models of myocardial inflammation are lacking. Here, we bioengineered a …